article thumbnail

Trends in the Clinical Characteristics and Outcome of Infective Endocarditis: A Nationwide Study From 2016 to 2021

Journal of the American Heart Association

This study sought to examine temporal trends in the clinical characteristics and inhospital occurrence of adverse outcomes of IE.Methods and ResultsUsing the Japan nationwide administrative database, we identified patients with IE in Japan from 2016 to 2021. per 100 000 population in 2016 to 2.59 in 2016 to 15.4%

article thumbnail

ADHD Incidence Trends Fluctuated from 2016 to 2023 in Adults, Adolescents

HCPLive

A new study showed ADHD incidence trends fluctuated between 2016-2023, with adult diagnoses rising post-COVID-19 and adolescent rates remaining stable after an initial decline.

article thumbnail

Abstract TP74: Trends in extracranial-intracranial bypass procedure from 2016-2019

Stroke Journal

In this study, we aim to study trends in EC-IC bypass throughout the years.Methods:Using the National Inpatient Sample 2016-2019, hospital admissions with carotid occlusive disease (COD), moyamoya, subarachnoid hemorrhage (SAH), unruptured intracranial aneurysm (UIA) were identified using ICD-10 diagnosis codes. in 2016, increasing to 60.8%

article thumbnail

Heat-Related Mortality Trends Worsened from 1999 to 2023

HCPLive

Heat-related mortality rates in the US notably grew between 1999 and 2023, particularly since 2016.

105
105
article thumbnail

The FDA calls them 'recalls,' yet the targeted medical devices often remain in use

Medical Xpress - Cardiology

In 2016, medical device giant Abbott issued a recall for its MitraClip cardiac device—"a Class I recall, the most serious type," the FDA said.

92
article thumbnail

PO-06-028 SHORT-TERM OUTCOMES OF LEADLESS PACEMAKER IMPLANTATION IN THE UNITED STATES – INSIGHT FROM NATIONAL READMISSION DATABASE 2016-2020

HeartRhythm

Since its first Food and Drug Administration (FDA) approval in 2016, there has been a significant uptrend in the utilization of leadless pacemakers (LL-PPM).

article thumbnail

PO-03-166 CHARACTERISTICS AND 5-YEAR TREND IN LEADLESS PACEMAKER IMPLANTATION IN THE UNITED STATES – INSIGHT FROM NATIONAL READMISSION DATABASE (2016-2020)

HeartRhythm

Leadless VVI pacemakers (LL-PPM), first approved by Food and Drug Administration (FDA) in 2016, emerged as an alternative for transvenous pacemakers to reduce device-related complications.